Back
Outlook Therapeutics 10K Form
Sell
5
OTLK
Outlook Therapeutics
Last Price:
1.54
Seasonality Move:
10.95%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive OTLK News And Ratings
See the #1 stock for the next 7 days that we like better than OTLK
OTLK Financial Statistics
Sales & Book Value
| Annual Sales: | $8.15M |
|---|---|
| Cash Flow: | $-19.51M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-3.57 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -10.77000 |
|---|---|
| Net Income (TTM): | $-94.05M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Outlook Therapeutics Earnings Forecast
Key Outlook Therapeutics Financial Ratios
- The Interest Expense is -2.64% of Operating Income.
- Per Share Earnings over the last 10 years have been positive in 7 years.
Outlook Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | OTLK |
| CUSIP: | 69012T |
| Website: | outlooktherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
OTLK Technical Analysis vs Fundamental Analysis
Sell
5
Outlook Therapeutics (OTLK)
is a Sell
Is Outlook Therapeutics a Buy or a Sell?
-
Outlook Therapeutics stock is rated a Sell
The current Outlook Therapeutics [OTLK] share price is $1.57. The Score for OTLK is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.